Targeting the glutamine to pyruvate pathway for treatment of oncogenic Kras-associated cancer
摘要
<p>Methods and kits for GPP-targeting, e.g., for the treatment of oncogenic Kras-associated cancers, and methods for determining the efficacy of those methods are provided.</p>
申请公布号
AU2013266243(A1)
申请公布日期
2014.12.18
申请号
AU20130266243
申请日期
2013.05.23
申请人
DANA-FARBER CANCER INSTITUTE, INC.;BETH ISRAEL DEACONESS MEDICAL CENTER, INC.
发明人
KIMMELMAN, ALEC;SON, JAEKYOUNG;CANTLEY, LEWIS;LYSSIOTIS, COSTAS A.
